The development assumes significance for India's $60-billion pharmaceutical industry amid concerns over the quality of drugs manufactured in the country. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground. Officials noted that further verified updates and administrative measures will be shared following a detailed review.